Notably, Egr1 has been reported to be a transcriptional target of SRC-211, 33 and is implicated in promotion of obesity and insulin resistance34, progression of prostate cancer35 and transcriptional regulation of lipid and cholesterol biosynthetic genes36. This evidence concerns the gene EGR1 and Obesity.